Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
You see in Canada tirzepatide is formally approved for use in type 2 diabetes, however physicians regularly prescribe it off label (meaning for a condition it is not yet formally indicated by regulators) for use with obesity while we wait for Health Canada approval (the FDA approved it for obesity on November 8th, 2023, while the EUs European Commission approved it for obesity on April 24th, 2024)
A person who weighs the same at month 10 as they did at month 8 but has gained 3 pounds of muscle and lost 3 pounds of fat looks dramatically different
However, it is important to consult with your medical team to determine the right weight loss options for your specific condition
Vials should be kept sealed, cold, and away from light and moisture, generally at or below -20C for long-term storage
Placebo does not
Aliment Pharmacol Ther 2009
